Luwei Xu

542 total citations
31 papers, 391 citations indexed

About

Luwei Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Luwei Xu has authored 31 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Luwei Xu's work include MicroRNA in disease regulation (5 papers), Prostate Cancer Treatment and Research (5 papers) and Circular RNAs in diseases (4 papers). Luwei Xu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Prostate Cancer Treatment and Research (5 papers) and Circular RNAs in diseases (4 papers). Luwei Xu collaborates with scholars based in China, Japan and United States. Luwei Xu's co-authors include Zheng Xu, Yu‐Zheng Ge, Liuhua Zhou, Jiageng Zhu, Rui-Peng Jia, Wencheng Li, Ruiyang Wu, Youcai Zhao, Hongbin Sun and Jianping Wu and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Medicine.

In The Last Decade

Luwei Xu

30 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luwei Xu China 12 174 157 141 46 44 31 391
Xinnian Yu China 13 182 1.0× 138 0.9× 84 0.6× 48 1.0× 82 1.9× 21 360
Ziling Huang China 11 171 1.0× 98 0.6× 171 1.2× 26 0.6× 86 2.0× 27 401
Duxun Tan China 7 191 1.1× 141 0.9× 148 1.0× 50 1.1× 81 1.8× 8 337
Cristina Fhied United States 11 123 0.7× 61 0.4× 111 0.8× 46 1.0× 83 1.9× 27 318
Yinghua Pan China 16 376 2.2× 225 1.4× 120 0.9× 34 0.7× 108 2.5× 21 609
Degang Ding China 11 176 1.0× 110 0.7× 62 0.4× 37 0.8× 31 0.7× 28 319
Yuxia Zhao China 12 193 1.1× 126 0.8× 69 0.5× 24 0.5× 79 1.8× 26 313
Carina Pereira Portugal 13 163 0.9× 134 0.9× 63 0.4× 73 1.6× 115 2.6× 31 453
Maedeh Barahman Iran 9 130 0.7× 67 0.4× 168 1.2× 21 0.5× 106 2.4× 31 357

Countries citing papers authored by Luwei Xu

Since Specialization
Citations

This map shows the geographic impact of Luwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwei Xu more than expected).

Fields of papers citing papers by Luwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwei Xu. The network helps show where Luwei Xu may publish in the future.

Co-authorship network of co-authors of Luwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Luwei Xu. A scholar is included among the top collaborators of Luwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luwei Xu. Luwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Su, et al.. (2025). Enhancement of CAR-T cell efficacy and persistence via CD30 costimulation and NF-κB signaling. Molecular Cancer. 24(1). 289–289.
2.
Zhang, Qijie, Junpeng Deng, Tengyue Zeng, et al.. (2025). Prone versus lateral retroperitoneoscopic partial nephrectomy for posterior tumors in adults: technique and clinical outcomes. Translational Andrology and Urology. 14(3). 567–577. 1 indexed citations
3.
Zhang, Yifan, et al.. (2025). The biogenesis and biological roles of migrasomes in human diseases. Cell Death Discovery. 11(1). 296–296. 1 indexed citations
4.
Zhang, Yifan, et al.. (2023). Exosomes from miR‐23 Overexpressing Stromal Cells Suppress M1 Macrophage and Inhibit Calcium Oxalate Deposition in Hyperoxaluria Rat Model. BioMed Research International. 2023(1). 2883623–2883623. 3 indexed citations
5.
Hong, Xi, Luwei Xu, Xinning Wang, et al.. (2022). Sirtuin 4 Inhibits Prostate Cancer Progression and Metastasis by Modulating p21 Nuclear Translocation and Glutamate Dehydrogenase 1 ADP-Ribosylation. Journal of Oncology. 2022. 1–18. 5 indexed citations
6.
Zhang, Yifan, et al.. (2022). Cystine crystal-induced reactive oxygen species associated with NLRP3 inflammasome activation: implications for the pathogenesis of cystine calculi. International Urology and Nephrology. 54(12). 3097–3106. 2 indexed citations
7.
Zhang, Lele, Wencheng Li, Zheng Xu, et al.. (2020). 68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 483–492. 56 indexed citations
8.
Qin, Zhiqiang, Luwei Xu, Zheng Xu, et al.. (2020). Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis. International braz j urol. 46(5). 691–704. 11 indexed citations
9.
Zhang, Yifan, Luwei Xu, Kai Liang, et al.. (2019). Protective effect of salvianolic acid B against oxidative injury associated with cystine stone formation. Urolithiasis. 47(6). 503–510. 8 indexed citations
10.
Ge, Yu‐Zheng, Tao Xu, Weijun Cao, et al.. (2017). A Molecular Signature of Two Long Non-Coding RNAs in Peripheral Blood Predicts Acute Renal Allograft Rejection. Cellular Physiology and Biochemistry. 44(3). 1213–1223. 19 indexed citations
11.
12.
Ge, Yu‐Zheng, Luwei Xu, Zheng Xu, et al.. (2015). Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma. Medicine. 94(16). e767–e767. 22 indexed citations
13.
Xu, Zheng, Yu‐Zheng Ge, Jiageng Zhu, et al.. (2015). MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival. Tumor Biology. 36(10). 8159–8166. 26 indexed citations
14.
Ge, Yu‐Zheng, Ruiyang Wu, Hui Xin, et al.. (2015). A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 141(7). 1291–1299. 39 indexed citations
15.
Sun, Hongbin, et al.. (2014). Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy. Asian Journal of Andrology. 16(5). 710–710. 17 indexed citations
16.
Ge, Yu‐Zheng, Yidan Wang, Zheng Xu, et al.. (2014). Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis. Tumor Biology. 35(7). 6405–6414. 7 indexed citations
17.
Ge, Yu‐Zheng, Qian Ge, Minghao Li, et al.. (2014). Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: A meta-analysis and systematic review. Human Immunology. 75(8). 827–832. 28 indexed citations
18.
Xu, Luwei, Ming Qian, Ruipeng Jia, et al.. (2012). Expression and Significance of Microsomal Prostaglandin Synthase-1 (mPGES-1) and Beclin-1 in the Development of Prostate Cancer. Asian Pacific Journal of Cancer Prevention. 13(4). 1639–1644. 9 indexed citations
19.
Su, Qi, Ruipeng Jia, Luwei Xu, et al.. (2010). Effect of endothelin-1 on cyclooxygenase-2 expression in human hormone refractory prostate cancer cells. Oncology Letters. 1(3). 495–499. 1 indexed citations
20.
Dmochowski, Roger R., et al.. (2009). 471 URODYNAMIC EFFECTS OF TADALAFIL 20 MG ONCE DAILY VERSUS PLACEBO IN MEN WITH SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA. European Urology Supplements. 8(4). 238–238. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinnian Yu Breakdown of academic impact, for papers by Ziling Huang Breakdown of academic impact, for papers by Duxun Tan Breakdown of academic impact, for papers by Cristina Fhied Breakdown of academic impact, for papers by Yinghua Pan Breakdown of academic impact, for papers by Degang Ding Breakdown of academic impact, for papers by Yuxia Zhao Breakdown of academic impact, for papers by Carina Pereira Breakdown of academic impact, for papers by Maedeh Barahman
Rankless by CCL
2026